Prevention of Secondary Infections by Interferon Gamma in ICU-acquired Sustained Immune-suppression

NCT06774235 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

326

Enrollment

OTHER

Sponsor class

Conditions

Sustained Immunosuppression

Interventions

DRUG: Interferon Gamma 1-b
DRUG: Placebo

Sponsor

University Hospital, Limoges